Arginase 1
Arginase 1 Molekülinformation
| Englischer Name | Arginase-1 | Anzahl der inverkehr gebrachten Arzneimittel | 0 |
| Anzahl der klinischen Arzneimittel | 2 | Target-Alias | EC:3.5.3.1，Liver-type arginase，Type I arginase，ARG1，Arginase 1，Arginase， Liver，Arginase-1，EC 3.5.3.1 |
| Höchste Forschungs- und Entwicklungsphase | Phase 2 Clinical | ||
| Englischer Name | Arginase-1 |
| Target-Alias | EC:3.5.3.1，Liver-type arginase，Type I arginase，ARG1，Arginase 1，Arginase， Liver，Arginase-1，EC 3.5.3.1 |
| Anzahl der inverkehr gebrachten Arzneimittel | 0 |
| Anzahl der klinischen Arzneimittel | 2 |
| Höchste Forschungs- und Entwicklungsphase | Phase 2 Clinical |
Arginase 1 Produktliste
- Attribut
Protein (1)
- Produktbibliothek
Online (1)
- Spezies
Human (1)
- Etikett
His Tag (1)
- Marker
Unconjugated (1)
| Produktnummer | Spezies | Expressionssystem | Produktbeschreibung | Proteinstruktur | Reinheit | Eigenschaften | Vorbestellen/Bestellen |
|---|---|---|---|---|---|---|---|
 Human | HEK293 | Human Arginase 1 / ARG1 Protein, His Tag |  |  |  In den Warenkorb legen |
Gesamtmenge1
- 1
Arginase 1 Molekülhintergrund
Arginase-1 (ARG1) is also known as Liver-type arginase, Type I arginase, which belongs to the arginase family. Arginase-1 / ARG1 is a manganese-containing enzyme. The reaction catalyzed by this enzyme is: arginine + H2O → ornithine + urea. It is the final enzyme of the urea cycle. Defects in Arginase-1 / ARG1 are the cause of argininemia (ARGIN).
Arginase 1 Molekülalias
ARG1,Arginase-1
Klinische Arzneimittelinformation
| Englischer Name | Forschungscode | Forschungsphase | Firma | Indikationen | Klinische Studie |
|---|---|---|---|---|---|
| Numidargistat | INCB-01158; CB-1158 | Phase 2 Clinical | Calithera Biosciences Inc | Biliary Tract Neoplasms; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Head and Neck Neoplasms; Lung Neoplasms; Mesothelioma; Multiple Myeloma; Neoplasm Metastasis; Ovarian Neoplasms; Solid tumours; Stomach Neoplasms; Urinary Bladder Neoplasms | Details |
| OATD-02 | OAT-1746; OATD-02; EX-A8043; HY-155108 | Phase 1 Clinical | OncoArendi Therapeutics Inc | Carcinoma, Renal Cell; Colorectal Neoplasms; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms | Details |
Produktrezensionen
1***32019-10-11
1Menschen mögenEnzyme activity is very high, basically there is no different from products of thermo and RD, but with a better price. The most impressive thing is that there is almost no difference on bioactivity among each batch, and the quality control is excellent!- 1***22019-09-27 1Menschen mögenI bought another product for our laboratory before. This time I needed to buy Human Arginase 1 / ARG1 Protein, His Tag. All my senior coworkers recommended me to buy from ACRO, so I bought one to try. Indeed, as expected, it was great. Product quality and customer service was also good.
- Molekülinformation
- Produktliste
- Produktrezensionen
- Klinische Arzneimittelinformation